Capex / revenue moved 743 bp higher
Capex / revenue changed +743 basis points from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capex / revenue changed +743 basis points from the comparable as-filed period.
Capital expenditure changed +391.5% from the comparable as-filed period.
Debt changed +13.8% from the comparable as-filed period.
Free-cash-flow proxy changed -386.5% from the comparable as-filed period.
Operating cash flow changed +132.0% from the comparable as-filed period. The change ranks at the 33th percentile of 6 prior comparable changes.
Operating income changed +49.1% from the comparable as-filed period.
Revenue changed +59.1% from the comparable as-filed period.
Inventory changed -16.9% from the comparable as-filed period.
Net income changed +14.2% from the comparable as-filed period.
Cash & equivalents changed -6.8% from the comparable as-filed period.
Operating margin changed -98 basis points from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.